EDITORIAL
Accepted on 04 Aug 2025
Editorial: Incretin-based Therapies in the Treatment of Metabolic Syndrome: Expanding Roles Beyond Weight Management
doi 10.3389/fendo.2025.1676718
- 164 views
- Frontiers in Endocrinology
- Clinical Diabetes
- Research Topics
- Incretin-based Therapies in the Treatment of Metabolic Syndrome: Expanding Roles Beyond Weight Management
Incretin-based Therapies in the Treatment of Metabolic Syndrome: Expanding Roles Beyond Weight Management
1,214
Total downloads
7,495
Total views and downloads
Articles
SYSTEMATIC REVIEW
Published on 17 Jul 2025
Efficacy and safety of tirzepatide for weight loss in patients with obesity or type 2 diabetes: a systematic review and meta-analysis
doi 10.3389/fendo.2025.1593134
- 1,809 views
ORIGINAL RESEARCH
Published on 07 Jul 2025
Genetic variability in sodium-glucose cotransporter 2 and glucagon-like peptide 1 receptor effect on glycemic and pressure control in type 2 diabetes patients treated with SGLT2 inhibitors and GLP-1RA in the everyday clinical practice
doi 10.3389/fendo.2025.1547920
- 962 views
ORIGINAL RESEARCH
Published on 22 May 2025
Prior metabolic surgery attenuates the weight-loss efficacy of liraglutide in patients with mild obesity
doi 10.3389/fendo.2025.1580159
- 1,095 views
ORIGINAL RESEARCH
Published on 04 Oct 2024
Predictive factors of response to liraglutide in patients with type 2 diabetes mellitus and metabolic syndrome
doi 10.3389/fendo.2024.1449558
- 1,342 views
